Puig Brands (PUIGb.MC), the prominent Spanish beauty conglomerate, announced on Monday a definitive agreement to acquire Esteve’s remaining 50% stake in ISDIN for a substantial €1.20 billion ($1.41 billion). This pivotal transaction grants Puig complete ownership of the brand, significantly strengthening its footprint in the rapidly expanding dermatology-linked skincare market. ISDIN is a globally recognised company specialising in innovative skincare products, developed in collaboration with dermatologists, to address a wide range of skin health concerns and conditions. This acquisition is poised to integrate a strong, scientifically-backed brand into Puig’s diversified portfolio.
According to a regulatory filing by Puig, the payment structure involves an initial outlay of €900 million for the 50% stake upon the deal’s closure, with the remaining €300 million deferred until the first quarter of 2029. The completion of the transaction is contingent on securing necessary regulatory approvals and is projected to finalise by the end of the first quarter of 2027. Puig plans to finance the acquisition through a combination of its own robust internal resources and strategic debt, with a commitment to maintaining its net debt to adjusted earnings before interest, tax, depreciation, and amortisation ratio below two times following the deal.
This strategic acquisition highlights Puig’s deliberate shift towards boosting its skincare exposure, a move deemed crucial amidst evolving market dynamics. The beauty group notes that demand for fragrances is experiencing a normalisation phase, while the Middle East travel retail sector continues to operate under considerable pressure. By assuming full control of ISDIN, Puig aims to leverage the robust growth trajectory within the derma-cosmetics segment, further solidifying its market leadership and diversifying its revenue streams beyond traditional fragrance categories. This strategic investment is set to bolster Puig’s long-term growth prospects.
